CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Preferred Stock Series A Preferred Stock	Preferred Stock Series B Preferred Stock	Preferred Stock	Common Stock Class A Common Stock	Additional Paid-In Capital	Accumulated other comprehensive loss	Accumulated Deficit	Total
Beginning Balance (in shares) at Dec. 31, 2020				4,950,129
Beginning Balance at Dec. 31, 2020				$ 4,950	$ 3,251,240		$ (25,737,640)	$ (22,481,450)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense					182,225			182,225
Net loss							(6,229,651)	(6,229,651)
Ending Balance at Mar. 31, 2021				$ 4,950	3,433,465		(31,967,291)	(28,528,876)
Ending Balance (in shares) at Mar. 31, 2021				4,950,129
Beginning Balance at Dec. 31, 2020	$ 21,119,940	$ 36,983,910	$ 58,103,850
Beginning Balance (in shares) at Dec. 31, 2020	2,495,933	3,619,292
Ending Balance at Mar. 31, 2021	$ 21,119,940	$ 36,983,910	58,103,850
Ending Balance (in shares) at Mar. 31, 2021	2,495,933	3,619,292
Beginning Balance (in shares) at Dec. 31, 2020				4,950,129
Beginning Balance at Dec. 31, 2020				$ 4,950	3,251,240		(25,737,640)	(22,481,450)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss								(22,751,389)
Ending Balance at Sep. 30, 2021				$ 25,938	206,761,467	$ (4,751)	(48,489,029)	158,293,625
Ending Balance (in shares) at Sep. 30, 2021				25,938,064
Beginning Balance at Dec. 31, 2020	$ 21,119,940	$ 36,983,910	58,103,850
Beginning Balance (in shares) at Dec. 31, 2020	2,495,933	3,619,292
Beginning Balance (in shares) at Mar. 31, 2021				4,950,129
Beginning Balance at Mar. 31, 2021				$ 4,950	3,433,465		(31,967,291)	(28,528,876)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options				$ 18	52,609			52,627
Issuance of common stock upon exercise of stock options (in shares)				17,499
Issuance of common stock upon exercise of warrants				$ 308	926,817			927,125
Issuance of common stock upon exercise of warrants (in shares)				308,308
Stock-based compensation expense					351,009			351,009
Net loss							(7,987,665)	(7,987,665)
Ending Balance at Jun. 30, 2021				$ 5,276	4,763,900		(39,954,956)	(35,185,780)
Ending Balance (in shares) at Jun. 30, 2021				5,275,936
Beginning Balance at Mar. 31, 2021	$ 21,119,940	$ 36,983,910	58,103,850
Beginning Balance (in shares) at Mar. 31, 2021	2,495,933	3,619,292
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net of issuance costs		$ 24,788,851	24,788,851
Issuance of convertible preferred stock, net of issuance costs (in shares)		2,412,853
Ending Balance at Jun. 30, 2021	$ 21,119,940	$ 61,772,761	82,892,701
Ending Balance (in shares) at Jun. 30, 2021	2,495,933	6,032,145
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options				$ 98	294,191			294,289
Issuance of common stock upon exercise of stock options (in shares)				97,847
Conversion of Preferred Stock into common stock	$ (21,119,940)	$ (61,772,761)	$ (82,892,701)	$ 11,939	82,880,762			82,892,701
Conversion of Preferred Stock into common stock (in shares)	(2,495,933)	(6,032,145)		11,939,281
Issuance of common stock upon initial public offering, net of issuance costs				$ 8,625	118,185,808			118,194,433
Issuance of common stock upon initial public offering, net of issuance costs (in shares)				8,625,000
Stock-based compensation expense					636,806			636,806
Net loss							(8,534,073)	(8,534,073)
Other comprehensive loss						(4,751)		(4,751)
Ending Balance at Sep. 30, 2021				$ 25,938	206,761,467	(4,751)	(48,489,029)	158,293,625
Ending Balance (in shares) at Sep. 30, 2021				25,938,064
Beginning Balance (in shares) at Dec. 31, 2021				26,320,199
Beginning Balance at Dec. 31, 2021				$ 26,320	215,276,186	(49,009)	(59,273,388)	155,980,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options				$ 63	193,048			193,111
Issuance of common stock upon exercise of stock options (in shares)				63,100
Stock-based compensation expense					897,650			897,650
Net loss							(12,896,374)	(12,896,374)
Other comprehensive loss						(118,386)		(118,386)
Ending Balance at Mar. 31, 2022				$ 26,383	216,366,884	(167,395)	(72,169,762)	144,056,110
Ending Balance (in shares) at Mar. 31, 2022				26,383,299
Beginning Balance (in shares) at Dec. 31, 2021				26,320,199
Beginning Balance at Dec. 31, 2021				$ 26,320	215,276,186	(49,009)	(59,273,388)	$ 155,980,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)								84,533
Net loss								$ (37,268,007)
Ending Balance at Sep. 30, 2022				$ 26,405	218,550,665	(142,473)	(96,541,395)	121,893,202
Ending Balance (in shares) at Sep. 30, 2022				26,404,732
Beginning Balance (in shares) at Mar. 31, 2022				26,383,299
Beginning Balance at Mar. 31, 2022				$ 26,383	216,366,884	(167,395)	(72,169,762)	144,056,110
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options				$ 9	27,775			27,784
Issuance of common stock upon exercise of stock options (in shares)				9,000
Stock-based compensation expense					1,052,421			1,052,421
Net loss							(11,527,303)	(11,527,303)
Other comprehensive loss						(14,166)		(14,166)
Ending Balance at Jun. 30, 2022				$ 26,392	217,447,080	(181,561)	(83,697,065)	133,594,846
Ending Balance (in shares) at Jun. 30, 2022				26,392,299
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options				$ 13	37,373			37,386
Issuance of common stock upon exercise of stock options (in shares)				12,433
Stock-based compensation expense					1,066,212			1,066,212
Net loss							(12,844,330)	(12,844,330)
Other comprehensive loss						39,088		39,088
Ending Balance at Sep. 30, 2022				$ 26,405	$ 218,550,665	$ (142,473)	$ (96,541,395)	$ 121,893,202
Ending Balance (in shares) at Sep. 30, 2022				26,404,732